Virusbasierte Expression von Proteinen und Genen
Anmelder: Sagitta Biotech 🇧🇪
Details
- Veröffentlichungs-Nr.
- EP4792829
- Anmeldetag
- 18. Februar 2025
- Veröffentlichung
- 19. August 2026
- Rechtsraum
- EP
Abstract
A nucleic acid molecule in the form of a plasmid comprising an origin of replication, a promoter for the transcription into viral RNA; a 3' NCT triplet upstream of regions for the insertion of gene(s) of interest, separated by Measeles virus intergenic regions, and one 5' NCT sharing at least 95% of identity with SEQ ID NO: 11 over its full-length, wherein the 3' NCT triplet shares at least 95% of identity with SEQ ID NO:14 over its full-length, the corresponding helper nucleic acid molecules, a process for the production of virosomes based on these nucleic acid based molecules, the obtained virosomes and their therapeutical uses.
Anmelder
- Firma
- Sagitta Biotech
- Land
- 🇧🇪 Belgien
Vertreten von
-
Calysta NV
Calysta NV · Diegem